Merrimack pharmaceuticals inc

Major-Pharmaceuticals

MACK


One Kendall Square
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 14.73
    $ +0.04 0.31 %
    Apr 19, 2024
  • 52-Week High/Low
  • $15 - $12.02
  • YTD
  • 9.8%

  • Trading Volume
  • 3,758
  • Market Cap Full
  • $ 210.9M
  • Shares Outstanding
  • 14.3M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 5.1% 6% -24.5% -21.5% 80.1% -5% -8.9% 61.8% 4.7% 10.1%
Q2 4.1% -35.6% -40.8% -36.7% -17.5% 4% 1.8% -5.9% 0.1% -0.1%
Q3 -31.2% 17.8% 17.3% 7.2% -21.1% 8% -24.4% -37% 0.2% -
Q4 -7.2% -35.8% -31.2% -26.9% -30.4% 72.3% -19.1% 213.1% 9.4% -
J F M A M J J A S O N D
2024 -0.1% 9.7% 0.5% -0.3% - - - - - - - -
2023 -1.3% -1% 7.1% 1% 0.9% -1.8% -2.4% 1.7% 1% -0.8% 3.2% 6.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    112%-30%-48%-63%-62%-17%115%-43%200%14%10%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.32 0.33 0.22 -1.33 -0.78 0.02 -0.05 -0.01 -0.02
Q2 0.21 0.40 0.22 -1.33 -0.71 -0.09 -0.06 -0.04 -0.03
Q3 0.38 0.23 0.40 0.3 -0.05 -0.08 -0.04 -0.03 -0.02
Q4 0.41 0.25 0.89 -0.67 0.24 -0.08 -0.03 -0.03 -
A 1.3 1.2 1.7 -3 -1.3 -0.23 -0.2 -0.1 -0.07

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2019
Q1 1.49668
Q2 0.50074
Q3 -
Q4 -
A 1.99742
2018 2019 2020 2021 2022 2023
Mar - 13.3 13.4 13.4 13.4 14.3
Jun 13.3 13.3 13.4 13.4 13.4 14.3
Sep 13.3 13.3 13.4 13.4 13.4 14.3
Dec 13.3 13.4 13.4 13.4 13.4 14.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - 0.2
Debt – Equity Ratio - - - - 0.3
Interest Coverage - - - 4.4 2.6
Equity multiplier - - - 0.1 0.2